Vimarsana
Biggest News Aggregation in the World

Moderna Collaboration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Moderna Collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Moderna Collaboration Today - Breaking & Trending Today

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Published: April 1, 2024

/PRNewswire/ -- Carisma Therapeutics Inc. (NASDAQ: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

Source: prnewswire.com
Related Topics:
United StatesJohn HohnekerSteven KellyShveta DigheChidozie UgwumbaPrnewswire Carisma Therapeutics IncCarisma Therapeutics IncModerna Tx IncCompany Annual Report On FormDrug AdministrationSesen Bio IncExchange CommissionBoard Of Directors The CompanyWhile The CompanyChief Executive OfficerPipeline UpdatesUpcoming MilestonesInvestigational New DrugModerna CollaborationFull YearCash EquivalentsSesen BioPrivate Securities Litigation Reform ActAnnual ReportConvertible Preferred Stock
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights - Vimarsana News

Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Published: November 9, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

Source: prnewswire.com
Related Topics:
United StatesSteven KellyUniversity Of Pennsylvania Abramson Cancer CenterSarah Cannon Cancer Research InstituteCity Of Hope National Medical CenterCompany Quarterly Report On FormExchange CommissionSociety For Immunotherapy Of CancerCarisma Therapeutics IncPrnewswire Carisma Therapeutics IncDrug AdministrationCompany PhaseOregon Health Science UniversityExchange Commission OnFred Hutchinson Cancer CenterMd Anderson Cancer CenterChief Executive OfficerRecent BusinessInvestigational New Drug ApplicationModerna CollaborationPennsylvania Abramson Cancer CenterHope National Medical CenterCancer CenterOregon HealthScience University
Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights - Vimarsana News

Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Published: August 10, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

Source: prnewswire.com
Related Topics:
United StatesSteven KellyLeadership TeamCompany PhaseVivo Oncology Program Moderna CollaborationPrnewswire Carisma Therapeutics IncFred Hutchinson Cancer CenterExchange CommissionDrug AdministrationUniversity Of Pennsylvania Abramson Cancer CenterCarisma Therapeutics IncSarah Cannon Cancer Research InstituteCity Of Hope National Medical CenterOregon Health Science UniversityCompany Quarterly Report On FormMd Anderson Cancer CenterExchange Commission OnChief Executive OfficerVivo Oncology ProgramModerna CollaborationEric SiegelGeneral CounselCorporate SecretaryTerry ShieldsSenior Vice President